News
05-15-2023, 06:42 PM
Announcing a new article publication for BIO Integration journal. Antibody-drug conjugates (ADCs) have the following advantages: target specificity; wide therapeutic index; and prolonged circulation half-life.
More... (https://www.news-medical.net/news/20230515/HER2-TPMC-proves-to-be-a-reasonable-alternative-for-HER2-positive-cancer-chemotherapeutics.aspx)
More... (https://www.news-medical.net/news/20230515/HER2-TPMC-proves-to-be-a-reasonable-alternative-for-HER2-positive-cancer-chemotherapeutics.aspx)